Fluoxetine is an antidepressant that has anti-infl ammatory and antihyperalgesic effects in experimental models of pain and infl ammation. The AIM of the present study was to determine the role of 5-HT 2 receptors in the mechanism of anti-infl ammatory and antihyperalgesic action of fl uoxetine after single and repeated administration of the drug. MATERIALS AND METHODS: 40 male Wistar rats were randomly divided in fi ve groups (n = 8) treated for 14 days with saline (control), diclofenac (positive control), fl uoxetine, cyproheptadine (5-HT 2 antagonist), and fl uoxetine + cyproheptadine, respectively. We used the experimental model of infl ammation induced by intraplantar injection of carrageenan and nociceptive test with mechanical pressure on the infl amed hind paw. RESULTS: Single and repeated administration of fl uoxetine showed that it had signifi cant anti-infl ammatory and antihyperalgesic effects when compared with the control (p < 0.05). Cyproheptadine did not change signifi cantly the anti-infl ammatory effect of fl uoxetine in the fi rst 4 hours, after a single administration. At 24 hours the combination did not differ statistically when compared with the control. Cyproheptadin did not change signifi cantly the anti-infl ammatory effect of fl uoxetine after repeated administration. After prolonged treatment the group that received fl uoxetine + cyproheptadine showed a statistically signifi cant increase in paw pressure to withdraw the hind paw compared with that treated with fl uoxetine alone (p < 0.05). CONCLUSIONS: Fluoxetine has anti-infl ammatory and antihyperalgesic effects in the carrageenan model of infl ammation. 5-HT 2 receptor mediated its anti-infl ammatory effect in single dose treated animals. Spinal 5-HT 2 receptors are involved in the antihyperalgesic effect of fl uoxetine after repeated administration.
tests using thermal stimulus, mechanical pressure of infl amed paw and formalin test. In wild type mice systemic injection of fl uoxetine elicits a strong analgesic effect in the same pain models excluding the fi rst phase of the formalin test. 7 The mechanism of the analgesic and anti-infl ammatory effect of fl uoxetine is not well understood. It increases the levels of serotonin which in turn acts on a number of receptor subtypes expressed in the CNS and peripheral tissues. There is evidence that suggests that 5-HT receptors induce spontaneous pain and hyperalgesia in the peripheral tissues where they mediate pro-infl ammatory effects of serotonin. 8 In contrast to the periphery in the CNS 5-HT 2 receptors probably mediate ant-infl ammatory and analgesic effect.
Carrageenan-induced paw edema is a frequently used experimental model of infl ammation. The tricyclic antidepressants amitriptyline, imipramine and clomipramine exhibit signifi cant anti-infl ammatory effect in this model. 9 
AIM
The aim of the present study was to determine the role of 5-HT 2 receptors in the mechanism of anti-infl ammatory and antihyperalgesic action of fl uoxetine after single and repeated administration of the drug. 
MATERIALS AND METHODS

The experiment was approved by the Ethics
INTRODUCTION
Fluoxetine is an antidepressant of the group of selective serotonin reuptake inhibitors (SSRI). It blocks serotonin transporter protein by high-affi nity mechanism and increases the concentration of this mediator in the central nervous system (CNS) and peripheral tissues. 1 It has been demonstrated that in addition to its main pharmacological antidepressive effect, fl uoxetine has an ant-infl ammatory activity. 2 Studies on the anti-infl ammatory activity of antidepressants are of interest in several areas. According to the neuroinfl ammatory hypothesis depressive disorders are related with infl ammation in some brain structures. 3 This raises the question about the possible involvement of the anti-infl ammatory effect of antidepressants in their therapeutic effi cacy in depression. On the other hand the anti-infl ammatory effect of antidepressants may be useful in the treatment of infl ammatory diseases that accompany depression or antidepressants can be used alone for this purpose. For example. there is clinical evidence that some antidepressants, such as bupropion can induce remission in Crohn's disease, psoriasis and atopic dermatitis. 4 Fluoxetine has analgesic activity in different experimental models of pain and antinociceptive tests. Singh et al. found that this antidepressant has pronounced analgesic effect in three classic pain tests -the tail-fl ick, hot plate and abdominal constrictor tests. They observed this effect after systemic and intracerebroventricular administration of fl uoxetine. 5 Furthermore, fl uoxetine delays development of tolerance to morphine analgesia. 6 In genetically modifi ed mice lacking central serotonergic neurons (line Lmx1b f/f/p ) the analgesic action of fl uoxeine is completely absent in pain relative humidity, room temperature 26.5 ± 1 °C and free access to food and tap-water. The experiments were conducted between 8:00 a.m. and 3:00 p.m. All groups were tested for analgesic and antiinfl ammatory activity after a single and repeated (14 days) treatment. For the groups treated with the receptor antagonist the latter was applied only on the day of the experiments.
EXPERIMENTAL METHODS
Carrageenan-induced paw edema.
The carrageenan-induced hind paw swelling was measured using a plethysmometer (Ugo Basile, Italy). Prior to treatment the volume of the right hind paw of the animals from all groups was measured. Thereafter all animals were given an intraplantar injection of 0.1 ml of 1% solution of carrageenan in 0.9% sodium chloride to induce an infl ammatory edema. Immediately after the injection of carrageenan animals from control group received 0.1 ml/100 g bw saline; the positive control group was treated with diclofenac sodium (25 mg/kg bw) and the animals in the experimental groups were injected the test substances i. p. In the groups treated with more than one substance the second substance was administered 30 minutes after the fi rst one. Hind paw volume was measured immediately before carrageenan injection and at 2, 3, 4 and 24 hours thereafter with a plethysmometer. The percentage of paw edema was calculated using the following equation:
Paw edema (%) = (V -V 0 )/V 0 x 100, where V is the paw volume at 2, 3, 4 and 24 hours after carrageenan injection and V 0 is the paw volume prior to carrageenan injection.
The animals were tested for anti-infl ammatory action on days 1 and 14 of treatment.
Nociceptive test with mechanical pressure of carrageenan-infl amed paw (analgesimeter).
The test was described by Randall & Selitto (1957) . Analgesimeter (Ugo Basile, Italy) is used in the test. This method is used for rapid precise screening of analgesic drugs. Mechanical pain stimulus is applied on a normal paw or an infl amed rat paw. Nociceptive threshold is measured by applying pressure on the infl amed rat hind paw. The strength of the pressure at which the animal withdraws testing paw is recorded. The maximal possible pressure is 250 grams (cut off). The rats were tested one hour before the treatment and at 1, 2 and 3 hours after the treatment. For groups treated with two drugs rats were tested at 1, 2 and 3 hours after the treatment with the second drug. The pressure at which the animal withdraws the hind paw was expressed as % of the maximum possible effect (MPE %), where MPE % = (post-treatment threshold -pretreatment threshold) x 100/(250 -pretreatment threshold).
STATISTICAL ANALYSIS Data were analyzed using the analysis of variance -One Way Anova from the software product SPSS 11.0. Mean values ± SEM were calculated. Nonparametric test of Kolmogorov-Smirnov show a normal distribution. A comparison of the results between groups was done using Independent -Samples T test. The results were considered signifi cant at p < 0.05.
RESULTS
Effect of cyproheptadine on the anti-infl ammatory action of fl uoxetine in carrageenan-induced infl ammatory reaction.
A single administration of fl uoxetine signifi cantly reduced carrageenan-induced paw edema in the early phase of carrageenan infl ammation (р = 0.04 at 2 hours and р = 0.01 at 4 hours) and at 24 hours (р < 0.0001) when compared with control. There was no statistically signifi cant difference between anti-infl ammatory effect of fl uoxetine and that of diclofenac, used as a reference ant-infl ammatory drug. Cyproheptadine reliably inhibited the early and late phase of carrageenan edema in comparison with the control. combination was more pronounced than that of the two substances administered separately. At 24 hours the combination did not differ signifi cantly when compared with the control but fl uoxetine (р < 0.0001) and cyproheptadine (р < 0.0001) alone signifi cantly reduced the carrageenan-induced infl ammatory edema (Fig. 1) .
After repeated treatment (14 day) fl uoxetine signifi cantly reduced carrageenan-induced edema at 2, 3, 4 hours (p < 0,0001 ) and at 24 hours (p = 0.01) when compared with the control. The antiinfl ammatory effect of fl uoxetine was signifi cantly lower than that of diclofenac only at 24 hour (p < 0.05). Cyproheptadin statistically signifi cantly inhibited the early and late stages of the carrageenan edema in comparison with the control, but did not alter signifi cantly the anti-infl ammatory effect of fl uoxetine. At 24 hours the extent of reduction of the edema from the combination (36.22%), although not statistically signifi cant, was more pronounced than that of fl uoxetine (49.11%), and cyproheptadine (52.98 %) administered alone (Fig. 2) . (Fig. 3) .
In the group with repeated administration of diclofenac we observed a signifi cant increase of MPE % at 2 hours (p = 0.01) and at 3 hours (p = 0.04) (in comparison with the controls). The group treated for 14 days with fl uoxetine in a dose of 20 mg/kg bw showed a signifi cant increase in the values of MPE % at 1 hour (p = 0.004), 2 hours (p = 0.003) and 3 hours (p < 0.0001 ) (Fig. 4) .
After single application, cyproheptadine did not change statistically signifi cantly the effect of fl uoxetine in the test with mechanical pressure of infl amed rat hind paw. In the group with coadministration of cyproheptadine and fl uoxetine we found a non-signifi cant decrease of MPE% at 2 and 3 hours, and at 3 hours the group treated with both agents did not differ statistically from the control.
After repeated administration the group that received fl uoxetine and cyproheptadine differed signifi cantly (decrease in MPE% was observed) from that treated with fl uoxetine alone (p = 0.03) (Figs 3, 4) .
DISCUSSION
The results in our study indicate that SSRI anti- 2 In the CNS, the 5-HT 2 receptors mediate antiinfl ammatory effect. In experimental conditions intracerebroventricular injection of exogenic 5-HT on rats with normal serotonin levels reduces carrageenan edema. 10 5-HT 2 receptors interact with 5-HT 3 receptors in CNS which in turn stimulate serotonin secretion. Cyproheptadine as antagonist of 5-HT 2 receptors should inhibit the observed ant-infl ammatory effect of fl uoxetine if it is realized by a central mechanism. In the present study cyproheptadine blocks this effect only 24 hours after single administration. The anti-infl ammatory effect of serotonin in the CNS can be explained with its neuroendocrine action. In situ hybridization on rat brain slices with oligopeptides showed an increase of corticotropin releasing hormone mRNA in the paraventricular nucleus and proopiomelanocortin in the anterior pituitary lobe upon stimulation of 5-HT 2a and 5-HT 2b receptors. The stimulation of ACTH secretion and hence of hydrocortisone from the adrenal glands is also mediated through the 5-HT 2 receptors. 11 Our data show that these central mechanisms play a limited role in the observed anti-infl ammatory effect of fl uoxetine and perhaps the increased concentration of serotonin in the brain is not the main mechanism to achieve this effect.
5-HT receptors expressed in the peripheral tissues mediate pro-infl ammatory effect of serotonin. Carrageenan-induced infl ammatory reaction through 5-HT 2 receptors stimulates the expression of the receptors for the calcitonin-gene related peptide (CGRP). CGRP that is released from both the peripheral and central terminals of primary afferent fi bers during the infl ammation leads to sensitization of nociceptors, nociceptive neurons in the spinal cord and dorsal root ganglia. Suplantar injection of a 5-HT 2 receptor antagonist ketanserine suppresses the increased expression of CGRP and inhibits hyperalgesia. 12 On the other hand the inhibition of these neurons by 5-HT 2 antagonists is not direct but is mediated by opioidergic mechanisms. fect occurs in both single and repeated (14 days) administration. The effect is comparable to that of fl uoxetine. Co-administration of fl uoxetine and cyproheptadine did not alter the anti-infl ammatory effect of the antidepressant with the exception of the 24 th hour after single dose treatment. The observed additive synergism can be attributed to the poor affi nity of the fl uoxetine for the 5-HT 2 receptors and its ability to block them. Studies have demonstrated the interesting fact that both the stimulation of these receptors (from agonists or SSRI) and their long-time blockade lead to down regulation. 13 These facts explain the lack of even transient pro-infl ammatory effect of fl uoxetine in the present study due to increased serotonin levels in the periphery. In the experimental model of inflammatory hyperalgesia cyproheptadine signifi cantly decreased the effect of fl uoxetine at 3 hours in continuously treated animals. Since behavioral responses in this test are mediated by centers in the spinal cord 14 we can assume that spinal 5-HT 2 receptors are essential in the mechanism of the antihyperalgesic effect of fl uoxetine after multiple dosing. Intratecal administration of 5-НТ 2А/2С receptor agonist α-methyl-5-hydroxytriptamine has an antinociceptive effect in the formalin test and chronic sciatic nerve injury. 15 A possible explanation for the antihyperalgesic effect of 5-HT 2 receptors in the spinal cord is that they stimulate the release of inhibitory neurotransmitters such as gamma-aminobutyric acid (GABA) from the interneurons in the spinal dorsal horn. There are studies which have shown that about 90% 5-HT 2A positive cells in the periaqueductal gray matter of the rat are immunoreactive for GABA. 16 It has been demonstrated using molecular genetic techniques that a small percentage (about 10%) of the cells in the rat spinal dorsal horn express mRNA for these receptors. 17 This location would mediate an antinociceptive effect due to induction of the GABA/glycinergic inhibitory potentials in spinal cord via 5-HT 2 receptor stimulation. 18 The weak role of these receptors in the analgesic action of fl uoxetine in the test with mechanical pressure of infl amed rat hind paw is probably due to the expression of inhibitory proteins -postsynaptic density protein. It has been found that administration of fl uoxetine with inhibitors of this protein enhances the analgesic effect mediated by 5-HT 2 receptors. 19 
CONCLUSIONS
Fluoxetine has anti-infl ammatory and antihyperalgesic effects in carrageenan model of infl ammation. Centrally localized 5-HT 2 receptor mediated its anti-infl ammatory effect only in single dose treated animals in the late phase of carrageenan infl ammation. Spinal 5-HT 2 receptors are involved in the antihyperalgesic effect of fl uoxetine after repeated administration.
